Author Profile
Cliff Katz
Phone: (212) 808-7609
101 Park Avenue
New York
NY
10178
United States
Channels
- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Bankruptcy
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Technology
- Whistleblower Law
- Workers' Compensation
- Law School
RSS
About
As a litigation associate with Kelley Drye, Cliff Katz has represented multinational pharmaceutical manufacturers in numerous federal and state actions across the country. Practicing out of the firm’s New York offices, Mr. Katz has been a part of a variety of offensive and defensive fact and expert discovery matters, motion practice, analyses of electronic claims data and government payment methodologies, and other trial preparation. Cliff, an able contributor to the firm’s blog FCA Alert, has defended more than 75 depositions of federal Medicare and Medicaid officials, state agency officials, pharmaceutical company employees, wholesalers, and other industry employees and government officials.
Education
Practice Areas
Bar and Court Admissions
Recent Articles
Par Files Complaint Against the Government Claiming that FDA's Off-Label Marketing Regulations Violate the First Amendment
Par filed a Complaint for Declaratory and Injunctive Relief against the United States, the U.S. Food & Drug Administration (FDA), the Commissioner of the FDA, and the Secretary of the Department of Health & Human Services seeking a declaratory judgment that the application of FDA off-label...
Update: Relators Run the Risk that Complaints in Voluntarily Dismissed Cases May Be Unsealed
Earlier this week we reported on a case in the U.S. District Court for the District of Columbia in which the court unsealed a relator's complaint after the relator voluntarily dismissed it, holding that "the rationale behind sealing FCA cases is to allow the United States ample time to...
Relators Run the Risk that Complaints in Voluntarily Dismissed FCA Cases May Be Unsealed
The False Claims Act provides that private persons who bring actions on behalf of the U.S. Government, called relators, file their complaints under seal. This means that a defendant, which is frequently a present or former employer of the relator, will not have access to the complaint or even...
NJ Appellate Court Holds that NJ False Claims Act Cannot Reach Conduct Occurring Before March 2008
The New Jersey Appellate Division for the Superior Court, Mercer County, recently held that the New Jersey False Claims Act, N.J.S.A. 2A:32C–1 to –15 and N.J.S.A. 2A:32C–17 to –18, which was enacted on January 1, 2008 and made effective on March 13, 2008, does not apply...
Amgen Seeks Supreme Court Review of Implied Certification Theory of Liability Under the False Claims Act
The U.S. Courts of Appeals have been wrestling with the reach of the False Claims Act when the actual claim submitted to the government is not “factually false.” Some courts have adopted a framework in which a claim that is true on its face can be considered “legally...